LexDanaLexDanabeta
Inventor

Srinivasan Babu

Inventor
San Diego, CA, US

Overview

20→
Patents
1989–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 20 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds39%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
C07CAcyclic or carbocyclic compounds14%
C07BGeneral methods of organic chemistry9%
A61KPreparations for medical, dental or toiletry purposes7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry5%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture2%
Y02ATechnologies for adaptation to climate change2%
Y02PClimate change mitigation technologies in the production or processing of goods2%
PatentTitleYear
10,947,218Aminopyridine derivatives and their use as selective ALK-2 inhibitors20219,315,471'Process of making hydroxylated cyclopentapyrimidine compounds and salts thereof'20168,895,729'Process for making thienopyrimidine compounds'20148,785,651'Method for manufacturing a boronic acid ester compound'20148,461,328'Tricyclic heterocyclic compounds, compositions and methods of use thereof'20138,431,694'Process for making thienopyrimidine compounds'20138,354,528'Process for making thienopyrimidine compounds'20137,173,059'Intermediates useful in the synthesis of HIV-protease inhibitors and methods for preparing the same'20076,774,243'Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates'20046,465,661'Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors'20026,392,067'Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors'20026,355,807'Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates'20026,316,625'Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors'20016,117,999'Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors'20006,084,107'Intermediates for making HIV-protease inhibitors'20005,925,759'Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors'19995,705,647'Intermediates for making HIV-protease inhibitors'19985,631,399'Process for the preparation of ethyl 3S-[[4-[[4-(aminoiminomethyl)phenyl]amino]-1,4-dioxobutyl]amino]-4-penty noate'19975,536,869'Process for the preparation of ethyl 3S-[4-[[4-(aminoiminomethyl)phenyl]amino]-1,4-dioxobutyl]amino]-4-pentyn oate'19964,868,304'Synthesis of nitrogen heterocycles'1989

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1989Based in Maryland Heights, MO, US· patent location history
1996–2014Based in San Diego, CA, US· patent location history
1998–2007Patents assigned to AGOURON PHARMA (9)· patent assignee history
1998–2002Patents assigned to JAPAN TOBACCO INC (4)· patent assignee history
2013–2016Patents assigned to GENENTECH INC (6)· patent assignee history
2013–2014Patents assigned to BABU SRINIVASAN (3)· patent assignee history
2013–2014Patents assigned to CHENG ZHIGANG (2)· patent assignee history
2013–2016Based in South San Francisco, CA, US· patent location history
2021Based in Hyderabad, IN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
AGOURON PHARMA91998–2007
GENENTECH INC62013–2016
JAPAN TOBACCO INC41998–2002
BABU SRINIVASANself32013–2014
CHENG ZHIGANG22013–2014
Locations
LocationPatentsSpan
San Diego, California, US151996–2014
South San Francisco, California, US32013–2016
Hyderabad, IN12021
Maryland Heights, MO, US11989